Stocks / AMEX / AEON Biopharma Inc.

AEON Biopharma Inc.

Industry: Health Care – Biotechnology: Pharmaceutical Preparations

Stock Symbol: AEON – AMEX

Animal Usage: Animal Testing

Our Opinion

AEON Biopharma Inc. is on the Cruelty Free Investing use of animals list because they conduct pre-clinical studies of their drugs on animals to assess a product’s safety profile.

Supporting Evidence:

The company stated in the following report that they exploit animals for product testing.

“For example, we are exploring the use of ABP-450 as a potential treatment for neuropsychiatric disorders and initiated a preclinical study of ABP-450 in animal models to characterize the safety and toxicology prior to entering human studies.” (Page 14) Read the full document

Company Description

AEON Biopharma, Inc., a clinical stage biopharmaceutical company, focuses on developing botulinum toxins. It develops ABP-450 (prabotulinumtoxinA) injection for debilitating medical conditions, which completed Phase 2 study for the treatment of cervical dystonia and has an ongoing Phase 2 study for the treatment of both chronic and episodic migraine, as well as develops ABP-450 for the treatment of gastroparesis and posttraumatic stress disorder. The company is based in Irvine, California.

Company Website: https://www.aeonbiopharma.com

Contact: https://aeonbiopharma.com/contact-aeon-biopharma/